Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Crinetics Pharmaceuticals, Inc. (CRNX) had Weighted-Average Shares Outstanding (Basic) of 94.06M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$6.16M |
|
$-122.81M |
|
-- |
|
$6.16M |
|
$139.83M |
|
$-133.67M |
|
$11.03M |
|
$-122.64M |
|
$-122.64M |
|
$-122.81M |
|
$-122.81M |
|
$-122.81M |
|
$-122.81M |
|
$-133.67M |
|
$-135.41M |
|
|
Weighted-Average Shares Outstanding (Basic) |
94.06M |
94.06M |
|
$-1.30 |
|
$-1.30 |
|
| Balance Sheet Financials | |
$1.05B |
|
$14.30M |
|
$77.92M |
|
$1.13B |
|
$85.07M |
|
-- |
|
$49.10M |
|
$134.17M |
|
$992.08M |
|
$992.08M |
|
$992.08M |
|
95.58M |
|
| Cash Flow Statement Financials | |
$-377.92M |
|
$173.91M |
|
$40.61M |
|
$265.85M |
|
$102.34M |
|
$-163.51M |
|
$91.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
82.54% |
|
-2169.55% |
|
-2169.55% |
|
-- |
|
-1990.51% |
|
-1993.43% |
|
$-383.68M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
10.41 |
|
8.65 |
|
-12.38% |
|
-12.38% |
|
-10.90% |
|
-12.38% |
|
$10.38 |
|
$-4.08 |
|
$-4.02 |
|